Drug Safety Information for TRILAFON (Perphenazine)

Adverse Drug Reactions for TRILAFON* (Perphenazine)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with TRILAFON
(reported in FDA Medwatch/FAERS Reports)

	Side Effect	# of FDA Reports
1	Diabetes mellitus	179
2	Type 2 diabetes mellitus	144
3	Weight increased*	90
4	Pancreatitis	62
5	Fatigue*	59
6	Tardive dyskinesia	58
7	Blood cholesterol increased	56
8	Dizziness	54
9	Drug interaction	54
10	Completed suicide	54
11	Drug ineffective	53
12	Hypertension	52
13	Insomnia	48
14	Hyperglycaemia	46
15	Asthenia	46
16	Dyspnoea	46
17	Depression	46
18	Death	44
19	Diabetes mellitus inadequate control	44
20	Hyperlipidaemia	43

* This side effect also appears in "Top 10 Side Effects of TRILAFON " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking TRILAFON
(associated with FDA Medwatch/FAERS Reports)

	Reason	# of FDA Reports
1	Product used for unknown indication	592
2	Schizophrenia	233
3	Psychotic disorder*	205
4	Depression	121
5	Bipolar disorder	113
6	Schizophrenia, paranoid type*	91
7	Schizoaffective disorder*	85
8	Mental disorder	50
9	Anxiety	48
10	Affective disorder	43

*Also a top-10 reason in AskaPatient Review Summary.

Types of Adverse Events for TRILAFON

Total Reports Filed with FDA: 6947

Number of FDA Adverse Event Reports by Patient Age for TRILAFON

Total Reports Filed with FDA: 6947*

* Reports for drugs with the same active ingredients have been aggregated in this analysis: Perphenazine (Trilafon, Perphenazine)

Charts are based on 6947 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Historical Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.